Expert consensus on clinical treatment dilemmas in elderly patients with atopic dermatitis

Abstract

Atopic dermatitis (AD) is a common chronic, recurrent, inflammatory skin disease. With the aging of the global population, the prevalence of atopic dermatitis is increasing in the elderly (>60 years old). This consensus was led by Dermatology Branch of Guangdong Elder Health Care Association, with a consensus writing committee comprising 12 experts. This consensus mainly discussed the epidemiology, pathogenesis, and unique clinical manifestations of atopic dermatitis in the elderly, the selection of topical medications, the role of new systemic drugs, and the specific application of traditional Chinese medicine and herbs, and appropriate recommendations. Through two rounds of online voting by all experts, one "strongly recommended" opinion and six "recommended" opinions were ultimately formed. The purpose of this article is to provide guidance and reference for clinical practitioners in the treatment of atopic dermatitis in elderly patients.

Keywords

• atopic dermatitis
• the elderly
• inflammatory skin diseases
• expert consensus
• biological agents
• jak inhibitors